<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0220401.ref019">
 <label>19</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Barr</surname>
   <given-names>IG</given-names>
  </name>, 
  <name>
   <surname>Donis</surname>
   <given-names>RO</given-names>
  </name>, 
  <name>
   <surname>Katz</surname>
   <given-names>JM</given-names>
  </name>, 
  <name>
   <surname>McCauley</surname>
   <given-names>JW</given-names>
  </name>, 
  <name>
   <surname>Odagiri</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Trusheim</surname>
   <given-names>H</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Cell culture-derived influenza vaccines in the severe 2017â€“2018 epidemic season: a step towards improved influenza vaccine effectiveness</article-title>. 
  <source>NPJ Vaccines</source>. 
  <year>2018</year>
  <month>10</month>
  <day>9</day>;
  <volume>3</volume>:
  <fpage>44</fpage>
  <pub-id pub-id-type="doi">10.1038/s41541-018-0079-z</pub-id>
  <?supplied-pmid 30323955?>
  <pub-id pub-id-type="pmid">30323955</pub-id>
 </mixed-citation>
</ref>
